Revvity Inc (RVTY)

100.61 -0.47 (-0.46%) USD  |  NYSE  |  May 03, 16:00
100.56 -0.05 (-0.05%) Pre-Market: 20:00
More

Revvity Research and Development Expense (Quarterly): 50.36M for March 31, 2024

Research and Development Expense (Quarterly) Chart

Historical Research and Development Expense (Quarterly) Data

View and export this data back to 1997. Upgrade now.
Date Value
March 31, 2024 50.36M
December 31, 2023 49.60M
September 30, 2023 53.04M
June 30, 2023 57.25M
March 31, 2023 56.69M
December 31, 2022 54.54M
September 30, 2022 53.52M
June 30, 2022 56.04M
March 31, 2022 57.52M
December 31, 2021 60.58M
September 30, 2021 49.42M
June 30, 2021 65.82M
March 31, 2021 60.22M
December 31, 2020 -2.125M
September 30, 2020 50.13M
June 30, 2020 49.52M
March 31, 2020 48.91M
December 31, 2019 47.64M
September 30, 2019 45.38M
June 30, 2019 48.34M
March 31, 2019 47.98M
December 31, 2018 51.97M
September 30, 2018 48.85M
June 30, 2018 47.20M
March 31, 2018 45.98M
Date Value
December 31, 2017 37.73M
September 30, 2017 34.88M
June 30, 2017 33.56M
March 31, 2017 33.29M
December 31, 2016 32.83M
September 30, 2016 29.51M
June 30, 2016 31.87M
March 31, 2016 29.97M
December 31, 2015 16.64M
September 30, 2015 31.10M
June 30, 2015 32.68M
March 31, 2015 32.12M
December 31, 2014 17.88M
September 30, 2014 30.44M
June 30, 2014 30.35M
March 31, 2014 29.38M
December 31, 2013 32.59M
September 30, 2013 31.41M
June 30, 2013 34.40M
March 31, 2013 34.18M
December 31, 2012 32.73M
September 30, 2012 32.41M
June 30, 2012 34.07M
March 31, 2012 32.62M
December 31, 2011 31.50M

R&D Expense Definition

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (Quarterly) Range, Past 5 Years

-2.125M
Minimum
Dec 2020
65.82M
Maximum
Jun 2021
50.62M
Average
51.70M
Median

Research and Development Expense (Quarterly) Benchmarks

Agilent Technologies Inc 128.00M
Bruker Corp 81.70M
Azenta Inc 8.493M
Harvard Bioscience Inc 3.15M
Bionano Genomics Inc 11.70M